JP2020517261A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020517261A5 JP2020517261A5 JP2019556929A JP2019556929A JP2020517261A5 JP 2020517261 A5 JP2020517261 A5 JP 2020517261A5 JP 2019556929 A JP2019556929 A JP 2019556929A JP 2019556929 A JP2019556929 A JP 2019556929A JP 2020517261 A5 JP2020517261 A5 JP 2020517261A5
- Authority
- JP
- Japan
- Prior art keywords
- cancer
- ifn
- cells
- mir
- cytokine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000003958 hematopoietic stem cell Anatomy 0.000 claims description 146
- 102000014150 Interferons Human genes 0.000 claims description 108
- 108010050904 Interferons Proteins 0.000 claims description 108
- 229940079322 interferon Drugs 0.000 claims description 108
- 102000004127 Cytokines Human genes 0.000 claims description 62
- 108090000695 Cytokines Proteins 0.000 claims description 62
- 206010028980 Neoplasm Diseases 0.000 claims description 60
- 210000002540 macrophage Anatomy 0.000 claims description 51
- 210000001616 monocyte Anatomy 0.000 claims description 49
- 239000013598 vector Substances 0.000 claims description 45
- -1 efrine B2 Proteins 0.000 claims description 43
- 210000001185 bone marrow Anatomy 0.000 claims description 42
- 210000001744 T-lymphocyte Anatomy 0.000 claims description 40
- 201000011510 cancer Diseases 0.000 claims description 38
- 210000000130 stem cell Anatomy 0.000 claims description 37
- 210000004027 cell Anatomy 0.000 claims description 36
- 108091028066 Mir-126 Proteins 0.000 claims description 32
- 239000000427 antigen Substances 0.000 claims description 29
- 102000036639 antigens Human genes 0.000 claims description 29
- 108091007433 antigens Proteins 0.000 claims description 29
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims description 28
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims description 28
- 239000002773 nucleotide Substances 0.000 claims description 28
- 125000003729 nucleotide group Chemical group 0.000 claims description 28
- 229940076838 Immune checkpoint inhibitor Drugs 0.000 claims description 27
- 102000037984 Inhibitory immune checkpoint proteins Human genes 0.000 claims description 27
- 108091008026 Inhibitory immune checkpoint proteins Proteins 0.000 claims description 27
- 108091008874 T cell receptors Proteins 0.000 claims description 27
- 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 27
- 239000012274 immune-checkpoint protein inhibitor Substances 0.000 claims description 27
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims description 26
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims description 26
- 239000002243 precursor Substances 0.000 claims description 24
- 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 23
- 230000002265 prevention Effects 0.000 claims description 16
- 230000003394 haemopoietic effect Effects 0.000 claims description 15
- 108090000623 proteins and genes Proteins 0.000 claims description 15
- ZADWXFSZEAPBJS-JTQLQIEISA-N 1-methyl-L-tryptophan Chemical compound C1=CC=C2N(C)C=C(C[C@H](N)C(O)=O)C2=C1 ZADWXFSZEAPBJS-JTQLQIEISA-N 0.000 claims description 13
- 102100024222 B-lymphocyte antigen CD19 Human genes 0.000 claims description 12
- 101000980825 Homo sapiens B-lymphocyte antigen CD19 Proteins 0.000 claims description 12
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims description 12
- 230000009261 transgenic effect Effects 0.000 claims description 10
- 102000004169 proteins and genes Human genes 0.000 claims description 9
- LKKMLIBUAXYLOY-UHFFFAOYSA-N 3-Amino-1-methyl-5H-pyrido[4,3-b]indole Chemical compound N1C2=CC=CC=C2C2=C1C=C(N)N=C2C LKKMLIBUAXYLOY-UHFFFAOYSA-N 0.000 claims description 8
- WEVYNIUIFUYDGI-UHFFFAOYSA-N 3-[6-[4-(trifluoromethoxy)anilino]-4-pyrimidinyl]benzamide Chemical compound NC(=O)C1=CC=CC(C=2N=CN=C(NC=3C=CC(OC(F)(F)F)=CC=3)C=2)=C1 WEVYNIUIFUYDGI-UHFFFAOYSA-N 0.000 claims description 8
- 102100030310 5,6-dihydroxyindole-2-carboxylic acid oxidase Human genes 0.000 claims description 8
- 102100038080 B-cell receptor CD22 Human genes 0.000 claims description 8
- 102100022005 B-lymphocyte antigen CD20 Human genes 0.000 claims description 8
- 102100024217 CAMPATH-1 antigen Human genes 0.000 claims description 8
- 102100032912 CD44 antigen Human genes 0.000 claims description 8
- 102100025570 Cancer/testis antigen 1 Human genes 0.000 claims description 8
- 206010009944 Colon cancer Diseases 0.000 claims description 8
- 108010066687 Epithelial Cell Adhesion Molecule Proteins 0.000 claims description 8
- 102100041003 Glutamate carboxypeptidase 2 Human genes 0.000 claims description 8
- 101000884305 Homo sapiens B-cell receptor CD22 Proteins 0.000 claims description 8
- 101000897405 Homo sapiens B-lymphocyte antigen CD20 Proteins 0.000 claims description 8
- 101000868273 Homo sapiens CD44 antigen Proteins 0.000 claims description 8
- 101000856237 Homo sapiens Cancer/testis antigen 1 Proteins 0.000 claims description 8
- 101000892862 Homo sapiens Glutamate carboxypeptidase 2 Proteins 0.000 claims description 8
- 101001133056 Homo sapiens Mucin-1 Proteins 0.000 claims description 8
- 101000610604 Homo sapiens Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 claims description 8
- 102100031413 L-dopachrome tautomerase Human genes 0.000 claims description 8
- 101710093778 L-dopachrome tautomerase Proteins 0.000 claims description 8
- 206010025323 Lymphomas Diseases 0.000 claims description 8
- 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 claims description 8
- 102000000440 Melanoma-associated antigen Human genes 0.000 claims description 8
- 102100034256 Mucin-1 Human genes 0.000 claims description 8
- 101710173694 Short transient receptor potential channel 2 Proteins 0.000 claims description 8
- 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 claims description 8
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims description 8
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 8
- 238000012737 microarray-based gene expression Methods 0.000 claims description 8
- 238000012243 multiplex automated genomic engineering Methods 0.000 claims description 8
- 210000001519 tissue Anatomy 0.000 claims description 8
- 102100023635 Alpha-fetoprotein Human genes 0.000 claims description 7
- 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims description 7
- 206010060862 Prostate cancer Diseases 0.000 claims description 7
- 108010072866 Prostate-Specific Antigen Proteins 0.000 claims description 7
- 102100038358 Prostate-specific antigen Human genes 0.000 claims description 7
- 208000000236 Prostatic Neoplasms Diseases 0.000 claims description 7
- 102000005962 receptors Human genes 0.000 claims description 7
- 108020003175 receptors Proteins 0.000 claims description 7
- ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 claims description 7
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 208000017604 Hodgkin disease Diseases 0.000 claims description 5
- 208000021519 Hodgkin lymphoma Diseases 0.000 claims description 5
- 208000010747 Hodgkins lymphoma Diseases 0.000 claims description 5
- 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims description 5
- 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 claims description 5
- 102100039688 Insulin-like growth factor 1 receptor Human genes 0.000 claims description 5
- 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 claims description 5
- 230000018044 dehydration Effects 0.000 claims description 5
- 238000006297 dehydration reaction Methods 0.000 claims description 5
- ZADWXFSZEAPBJS-UHFFFAOYSA-N racemic N-methyl tryptophan Natural products C1=CC=C2N(C)C=C(CC(N)C(O)=O)C2=C1 ZADWXFSZEAPBJS-UHFFFAOYSA-N 0.000 claims description 5
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 claims description 4
- WEYNBWVKOYCCQT-UHFFFAOYSA-N 1-(3-chloro-4-methylphenyl)-3-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)thio]ethyl}urea Chemical compound O1C(CN(C)C)=CC=C1CSCCNC(=O)NC1=CC=C(C)C(Cl)=C1 WEYNBWVKOYCCQT-UHFFFAOYSA-N 0.000 claims description 4
- 101710163881 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 claims description 4
- 208000024893 Acute lymphoblastic leukemia Diseases 0.000 claims description 4
- 208000031261 Acute myeloid leukaemia Diseases 0.000 claims description 4
- 102100021305 Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Human genes 0.000 claims description 4
- 101710137115 Adenylyl cyclase-associated protein 1 Proteins 0.000 claims description 4
- 201000003076 Angiosarcoma Diseases 0.000 claims description 4
- 101000719121 Arabidopsis thaliana Protein MEI2-like 1 Proteins 0.000 claims description 4
- 102100035526 B melanoma antigen 1 Human genes 0.000 claims description 4
- 208000032791 BCR-ABL1 positive chronic myelogenous leukemia Diseases 0.000 claims description 4
- 206010006187 Breast cancer Diseases 0.000 claims description 4
- 208000026310 Breast neoplasm Diseases 0.000 claims description 4
- 101710149863 C-C chemokine receptor type 4 Proteins 0.000 claims description 4
- 102100032976 CCR4-NOT transcription complex subunit 6 Human genes 0.000 claims description 4
- 102000017420 CD3 protein, epsilon/gamma/delta subunit Human genes 0.000 claims description 4
- 108050005493 CD3 protein, epsilon/gamma/delta subunit Proteins 0.000 claims description 4
- 101150013553 CD40 gene Proteins 0.000 claims description 4
- 108010065524 CD52 Antigen Proteins 0.000 claims description 4
- 241000282836 Camelus dromedarius Species 0.000 claims description 4
- 102100039510 Cancer/testis antigen 2 Human genes 0.000 claims description 4
- 102100026548 Caspase-8 Human genes 0.000 claims description 4
- 108090000538 Caspase-8 Proteins 0.000 claims description 4
- 102100025064 Cellular tumor antigen p53 Human genes 0.000 claims description 4
- 206010008342 Cervix carcinoma Diseases 0.000 claims description 4
- 101710178046 Chorismate synthase 1 Proteins 0.000 claims description 4
- 208000010833 Chronic myeloid leukaemia Diseases 0.000 claims description 4
- 208000001333 Colorectal Neoplasms Diseases 0.000 claims description 4
- 102100032768 Complement receptor type 2 Human genes 0.000 claims description 4
- 102000013701 Cyclin-Dependent Kinase 4 Human genes 0.000 claims description 4
- 108010025464 Cyclin-Dependent Kinase 4 Proteins 0.000 claims description 4
- 101710152695 Cysteine synthase 1 Proteins 0.000 claims description 4
- 101100481408 Danio rerio tie2 gene Proteins 0.000 claims description 4
- 206010014733 Endometrial cancer Diseases 0.000 claims description 4
- 206010014759 Endometrial neoplasm Diseases 0.000 claims description 4
- 102100038083 Endosialin Human genes 0.000 claims description 4
- 101710144543 Endosialin Proteins 0.000 claims description 4
- 102000018651 Epithelial Cell Adhesion Molecule Human genes 0.000 claims description 4
- 102100031940 Epithelial cell adhesion molecule Human genes 0.000 claims description 4
- 208000000461 Esophageal Neoplasms Diseases 0.000 claims description 4
- 102100038595 Estrogen receptor Human genes 0.000 claims description 4
- 102100028043 Fibroblast growth factor 3 Human genes 0.000 claims description 4
- 102100028075 Fibroblast growth factor 6 Human genes 0.000 claims description 4
- 108090000382 Fibroblast growth factor 6 Proteins 0.000 claims description 4
- 102100037362 Fibronectin Human genes 0.000 claims description 4
- 108010067306 Fibronectins Proteins 0.000 claims description 4
- 102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 claims description 4
- 108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 claims description 4
- 108010001515 Galectin 4 Proteins 0.000 claims description 4
- 102000000805 Galectin 4 Human genes 0.000 claims description 4
- 101710121810 Galectin-9 Proteins 0.000 claims description 4
- 102100031351 Galectin-9 Human genes 0.000 claims description 4
- 208000032612 Glial tumor Diseases 0.000 claims description 4
- 206010018338 Glioma Diseases 0.000 claims description 4
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 claims description 4
- 102100030595 HLA class II histocompatibility antigen gamma chain Human genes 0.000 claims description 4
- 102000006354 HLA-DR Antigens Human genes 0.000 claims description 4
- 108010058597 HLA-DR Antigens Proteins 0.000 claims description 4
- 208000001258 Hemangiosarcoma Diseases 0.000 claims description 4
- 102100021866 Hepatocyte growth factor Human genes 0.000 claims description 4
- 101000773083 Homo sapiens 5,6-dihydroxyindole-2-carboxylic acid oxidase Proteins 0.000 claims description 4
- 101001042227 Homo sapiens Acyl-CoA:lysophosphatidylglycerol acyltransferase 1 Proteins 0.000 claims description 4
- 101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 claims description 4
- 101000980814 Homo sapiens CAMPATH-1 antigen Proteins 0.000 claims description 4
- 101000889345 Homo sapiens Cancer/testis antigen 2 Proteins 0.000 claims description 4
- 101000721661 Homo sapiens Cellular tumor antigen p53 Proteins 0.000 claims description 4
- 101000941929 Homo sapiens Complement receptor type 2 Proteins 0.000 claims description 4
- 101001082627 Homo sapiens HLA class II histocompatibility antigen gamma chain Proteins 0.000 claims description 4
- 101000898034 Homo sapiens Hepatocyte growth factor Proteins 0.000 claims description 4
- 101001103039 Homo sapiens Inactive tyrosine-protein kinase transmembrane receptor ROR1 Proteins 0.000 claims description 4
- 101001034652 Homo sapiens Insulin-like growth factor 1 receptor Proteins 0.000 claims description 4
- 101001046677 Homo sapiens Integrin alpha-V Proteins 0.000 claims description 4
- 101001057504 Homo sapiens Interferon-stimulated gene 20 kDa protein Proteins 0.000 claims description 4
- 101001055144 Homo sapiens Interleukin-2 receptor subunit alpha Proteins 0.000 claims description 4
- 101000998120 Homo sapiens Interleukin-3 receptor subunit alpha Proteins 0.000 claims description 4
- 101001076408 Homo sapiens Interleukin-6 Proteins 0.000 claims description 4
- 101000777628 Homo sapiens Leukocyte antigen CD37 Proteins 0.000 claims description 4
- 101000878605 Homo sapiens Low affinity immunoglobulin epsilon Fc receptor Proteins 0.000 claims description 4
- 101001051093 Homo sapiens Low-density lipoprotein receptor Proteins 0.000 claims description 4
- 101001134060 Homo sapiens Melanocyte-stimulating hormone receptor Proteins 0.000 claims description 4
- 101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 claims description 4
- 101000934338 Homo sapiens Myeloid cell surface antigen CD33 Proteins 0.000 claims description 4
- 101000581981 Homo sapiens Neural cell adhesion molecule 1 Proteins 0.000 claims description 4
- 101001103036 Homo sapiens Nuclear receptor ROR-alpha Proteins 0.000 claims description 4
- 101001098352 Homo sapiens OX-2 membrane glycoprotein Proteins 0.000 claims description 4
- 101000874141 Homo sapiens Probable ATP-dependent RNA helicase DDX43 Proteins 0.000 claims description 4
- 101000880770 Homo sapiens Protein SSX2 Proteins 0.000 claims description 4
- 101000743264 Homo sapiens RNA-binding protein 6 Proteins 0.000 claims description 4
- 101001109419 Homo sapiens RNA-binding protein NOB1 Proteins 0.000 claims description 4
- 101001012157 Homo sapiens Receptor tyrosine-protein kinase erbB-2 Proteins 0.000 claims description 4
- 101000738771 Homo sapiens Receptor-type tyrosine-protein phosphatase C Proteins 0.000 claims description 4
- 101000857677 Homo sapiens Runt-related transcription factor 1 Proteins 0.000 claims description 4
- 101000633784 Homo sapiens SLAM family member 7 Proteins 0.000 claims description 4
- 101000868152 Homo sapiens Son of sevenless homolog 1 Proteins 0.000 claims description 4
- 101000874179 Homo sapiens Syndecan-1 Proteins 0.000 claims description 4
- 101000716102 Homo sapiens T-cell surface glycoprotein CD4 Proteins 0.000 claims description 4
- 101000934341 Homo sapiens T-cell surface glycoprotein CD5 Proteins 0.000 claims description 4
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims description 4
- 101000648075 Homo sapiens Trafficking protein particle complex subunit 1 Proteins 0.000 claims description 4
- 101000904724 Homo sapiens Transmembrane glycoprotein NMB Proteins 0.000 claims description 4
- 101000801433 Homo sapiens Trophoblast glycoprotein Proteins 0.000 claims description 4
- 101000610605 Homo sapiens Tumor necrosis factor receptor superfamily member 10A Proteins 0.000 claims description 4
- 101000851376 Homo sapiens Tumor necrosis factor receptor superfamily member 8 Proteins 0.000 claims description 4
- 101000851007 Homo sapiens Vascular endothelial growth factor receptor 2 Proteins 0.000 claims description 4
- 102000038455 IGF Type 1 Receptor Human genes 0.000 claims description 4
- 101710123134 Ice-binding protein Proteins 0.000 claims description 4
- 101710082837 Ice-structuring protein Proteins 0.000 claims description 4
- 108010073816 IgE Receptors Proteins 0.000 claims description 4
- 102000009438 IgE Receptors Human genes 0.000 claims description 4
- 102100039615 Inactive tyrosine-protein kinase transmembrane receptor ROR1 Human genes 0.000 claims description 4
- 108090000723 Insulin-Like Growth Factor I Proteins 0.000 claims description 4
- 102000004218 Insulin-Like Growth Factor I Human genes 0.000 claims description 4
- 108050002021 Integrator complex subunit 2 Proteins 0.000 claims description 4
- 102100022337 Integrin alpha-V Human genes 0.000 claims description 4
- 108010042918 Integrin alpha5beta1 Proteins 0.000 claims description 4
- 108010047852 Integrin alphaVbeta3 Proteins 0.000 claims description 4
- 102100027268 Interferon-stimulated gene 20 kDa protein Human genes 0.000 claims description 4
- 102000003816 Interleukin-13 Human genes 0.000 claims description 4
- 108090000176 Interleukin-13 Proteins 0.000 claims description 4
- 108010038453 Interleukin-2 Receptors Proteins 0.000 claims description 4
- 102000010789 Interleukin-2 Receptors Human genes 0.000 claims description 4
- 102100033493 Interleukin-3 receptor subunit alpha Human genes 0.000 claims description 4
- 102000004889 Interleukin-6 Human genes 0.000 claims description 4
- 108090001005 Interleukin-6 Proteins 0.000 claims description 4
- 208000008839 Kidney Neoplasms Diseases 0.000 claims description 4
- 102100031586 Leukocyte antigen CD37 Human genes 0.000 claims description 4
- 102100038007 Low affinity immunoglobulin epsilon Fc receptor Human genes 0.000 claims description 4
- 102100024640 Low-density lipoprotein receptor Human genes 0.000 claims description 4
- 206010058467 Lung neoplasm malignant Diseases 0.000 claims description 4
- 108010010995 MART-1 Antigen Proteins 0.000 claims description 4
- 108700018351 Major Histocompatibility Complex Proteins 0.000 claims description 4
- 102100034216 Melanocyte-stimulating hormone receptor Human genes 0.000 claims description 4
- 102000003735 Mesothelin Human genes 0.000 claims description 4
- 108090000015 Mesothelin Proteins 0.000 claims description 4
- 108010006035 Metalloproteases Proteins 0.000 claims description 4
- 102000005741 Metalloproteases Human genes 0.000 claims description 4
- 102100023123 Mucin-16 Human genes 0.000 claims description 4
- 101100481410 Mus musculus Tek gene Proteins 0.000 claims description 4
- 208000033761 Myelogenous Chronic BCR-ABL Positive Leukemia Diseases 0.000 claims description 4
- 102100025243 Myeloid cell surface antigen CD33 Human genes 0.000 claims description 4
- 102000003505 Myosin Human genes 0.000 claims description 4
- 108060008487 Myosin Proteins 0.000 claims description 4
- 102100027347 Neural cell adhesion molecule 1 Human genes 0.000 claims description 4
- 206010029260 Neuroblastoma Diseases 0.000 claims description 4
- 102100037589 OX-2 membrane glycoprotein Human genes 0.000 claims description 4
- 206010030155 Oesophageal carcinoma Diseases 0.000 claims description 4
- 108060006580 PRAME Proteins 0.000 claims description 4
- 102000036673 PRAME Human genes 0.000 claims description 4
- 102100034640 PWWP domain-containing DNA repair factor 3A Human genes 0.000 claims description 4
- 108050007154 PWWP domain-containing DNA repair factor 3A Proteins 0.000 claims description 4
- 206010061902 Pancreatic neoplasm Diseases 0.000 claims description 4
- 206010035226 Plasma cell myeloma Diseases 0.000 claims description 4
- 208000006664 Precursor Cell Lymphoblastic Leukemia-Lymphoma Diseases 0.000 claims description 4
- 102100035724 Probable ATP-dependent RNA helicase DDX43 Human genes 0.000 claims description 4
- 102100032831 Protein ITPRID2 Human genes 0.000 claims description 4
- 102100037686 Protein SSX2 Human genes 0.000 claims description 4
- 102000014128 RANK Ligand Human genes 0.000 claims description 4
- 108010025832 RANK Ligand Proteins 0.000 claims description 4
- 102100038150 RNA-binding protein 6 Human genes 0.000 claims description 4
- 102100022491 RNA-binding protein NOB1 Human genes 0.000 claims description 4
- 108091005682 Receptor kinases Proteins 0.000 claims description 4
- 102100030086 Receptor tyrosine-protein kinase erbB-2 Human genes 0.000 claims description 4
- 102100037422 Receptor-type tyrosine-protein phosphatase C Human genes 0.000 claims description 4
- 206010038389 Renal cancer Diseases 0.000 claims description 4
- 102100025373 Runt-related transcription factor 1 Human genes 0.000 claims description 4
- 102100029198 SLAM family member 7 Human genes 0.000 claims description 4
- 206010039491 Sarcoma Diseases 0.000 claims description 4
- 101710173693 Short transient receptor potential channel 1 Proteins 0.000 claims description 4
- 208000021712 Soft tissue sarcoma Diseases 0.000 claims description 4
- 208000005718 Stomach Neoplasms Diseases 0.000 claims description 4
- 102100036234 Synaptonemal complex protein 1 Human genes 0.000 claims description 4
- 101710143177 Synaptonemal complex protein 1 Proteins 0.000 claims description 4
- 102100035721 Syndecan-1 Human genes 0.000 claims description 4
- 102100036011 T-cell surface glycoprotein CD4 Human genes 0.000 claims description 4
- 102100025244 T-cell surface glycoprotein CD5 Human genes 0.000 claims description 4
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims description 4
- 108700019889 TEL-AML1 fusion Proteins 0.000 claims description 4
- 102100033082 TNF receptor-associated factor 3 Human genes 0.000 claims description 4
- 101001051488 Takifugu rubripes Neural cell adhesion molecule L1 Proteins 0.000 claims description 4
- 208000024770 Thyroid neoplasm Diseases 0.000 claims description 4
- 102100025256 Trafficking protein particle complex subunit 1 Human genes 0.000 claims description 4
- 102100023935 Transmembrane glycoprotein NMB Human genes 0.000 claims description 4
- 102100033579 Trophoblast glycoprotein Human genes 0.000 claims description 4
- LVTKHGUGBGNBPL-UHFFFAOYSA-N Trp-P-1 Chemical compound N1C2=CC=CC=C2C2=C1C(C)=C(N)N=C2C LVTKHGUGBGNBPL-UHFFFAOYSA-N 0.000 claims description 4
- 102100036922 Tumor necrosis factor ligand superfamily member 13B Human genes 0.000 claims description 4
- 101710181056 Tumor necrosis factor ligand superfamily member 13B Proteins 0.000 claims description 4
- 102100040113 Tumor necrosis factor receptor superfamily member 10A Human genes 0.000 claims description 4
- 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 claims description 4
- 102100036857 Tumor necrosis factor receptor superfamily member 8 Human genes 0.000 claims description 4
- 101710107540 Type-2 ice-structuring protein Proteins 0.000 claims description 4
- 102000003425 Tyrosinase Human genes 0.000 claims description 4
- 108060008724 Tyrosinase Proteins 0.000 claims description 4
- 208000006105 Uterine Cervical Neoplasms Diseases 0.000 claims description 4
- 102000009524 Vascular Endothelial Growth Factor A Human genes 0.000 claims description 4
- 108010053096 Vascular Endothelial Growth Factor Receptor-1 Proteins 0.000 claims description 4
- 102100033178 Vascular endothelial growth factor receptor 1 Human genes 0.000 claims description 4
- 102100033177 Vascular endothelial growth factor receptor 2 Human genes 0.000 claims description 4
- 108010065472 Vimentin Proteins 0.000 claims description 4
- 102000013127 Vimentin Human genes 0.000 claims description 4
- 208000009956 adenocarcinoma Diseases 0.000 claims description 4
- 229950001537 amatuximab Drugs 0.000 claims description 4
- 230000003302 anti-idiotype Effects 0.000 claims description 4
- 210000000013 bile duct Anatomy 0.000 claims description 4
- 201000009036 biliary tract cancer Diseases 0.000 claims description 4
- 208000020790 biliary tract neoplasm Diseases 0.000 claims description 4
- 201000010881 cervical cancer Diseases 0.000 claims description 4
- 208000029742 colonic neoplasm Diseases 0.000 claims description 4
- 229950010640 ensituximab Drugs 0.000 claims description 4
- 201000004101 esophageal cancer Diseases 0.000 claims description 4
- 108010038795 estrogen receptors Proteins 0.000 claims description 4
- 230000001605 fetal effect Effects 0.000 claims description 4
- 102000006815 folate receptor Human genes 0.000 claims description 4
- 108020005243 folate receptor Proteins 0.000 claims description 4
- 102000036215 folic acid binding proteins Human genes 0.000 claims description 4
- 108091011001 folic acid binding proteins Proteins 0.000 claims description 4
- 150000002270 gangliosides Chemical class 0.000 claims description 4
- 206010017758 gastric cancer Diseases 0.000 claims description 4
- 201000010536 head and neck cancer Diseases 0.000 claims description 4
- 208000014829 head and neck neoplasm Diseases 0.000 claims description 4
- 201000010982 kidney cancer Diseases 0.000 claims description 4
- 201000007270 liver cancer Diseases 0.000 claims description 4
- 208000014018 liver neoplasm Diseases 0.000 claims description 4
- 201000005202 lung cancer Diseases 0.000 claims description 4
- 208000020816 lung neoplasm Diseases 0.000 claims description 4
- 208000003747 lymphoid leukemia Diseases 0.000 claims description 4
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 claims description 4
- 201000001441 melanoma Diseases 0.000 claims description 4
- PUPNJSIFIXXJCH-UHFFFAOYSA-N n-(4-hydroxyphenyl)-2-(1,1,3-trioxo-1,2-benzothiazol-2-yl)acetamide Chemical compound C1=CC(O)=CC=C1NC(=O)CN1S(=O)(=O)C2=CC=CC=C2C1=O PUPNJSIFIXXJCH-UHFFFAOYSA-N 0.000 claims description 4
- 201000008968 osteosarcoma Diseases 0.000 claims description 4
- 201000002528 pancreatic cancer Diseases 0.000 claims description 4
- 208000008443 pancreatic carcinoma Diseases 0.000 claims description 4
- 102000003998 progesterone receptors Human genes 0.000 claims description 4
- 108090000468 progesterone receptors Proteins 0.000 claims description 4
- 235000002020 sage Nutrition 0.000 claims description 4
- 201000011549 stomach cancer Diseases 0.000 claims description 4
- 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 claims description 4
- 208000011580 syndromic disease Diseases 0.000 claims description 4
- 101150047061 tag-72 gene Proteins 0.000 claims description 4
- 201000002510 thyroid cancer Diseases 0.000 claims description 4
- 210000005048 vimentin Anatomy 0.000 claims description 4
- 206010061692 Benign muscle neoplasm Diseases 0.000 claims description 3
- 102000008857 Ferritin Human genes 0.000 claims description 3
- 108050000784 Ferritin Proteins 0.000 claims description 3
- 238000008416 Ferritin Methods 0.000 claims description 3
- 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 claims description 3
- 108010075704 HLA-A Antigens Proteins 0.000 claims description 3
- 102100037931 Harmonin Human genes 0.000 claims description 3
- 101000805947 Homo sapiens Harmonin Proteins 0.000 claims description 3
- 208000034578 Multiple myelomas Diseases 0.000 claims description 3
- 201000004458 Myoma Diseases 0.000 claims description 3
- SUHQNCLNRUAGOO-UHFFFAOYSA-N N-glycoloyl-neuraminic acid Natural products OCC(O)C(O)C(O)C(NC(=O)CO)C(O)CC(=O)C(O)=O SUHQNCLNRUAGOO-UHFFFAOYSA-N 0.000 claims description 3
- FDJKUWYYUZCUJX-UHFFFAOYSA-N N-glycolyl-beta-neuraminic acid Natural products OCC(O)C(O)C1OC(O)(C(O)=O)CC(O)C1NC(=O)CO FDJKUWYYUZCUJX-UHFFFAOYSA-N 0.000 claims description 3
- FDJKUWYYUZCUJX-KVNVFURPSA-N N-glycolylneuraminic acid Chemical compound OC[C@H](O)[C@H](O)[C@@H]1O[C@](O)(C(O)=O)C[C@H](O)[C@H]1NC(=O)CO FDJKUWYYUZCUJX-KVNVFURPSA-N 0.000 claims description 3
- 208000015914 Non-Hodgkin lymphomas Diseases 0.000 claims description 3
- 206010033128 Ovarian cancer Diseases 0.000 claims description 3
- 206010061535 Ovarian neoplasm Diseases 0.000 claims description 3
- 102100035748 Squamous cell carcinoma antigen recognized by T-cells 3 Human genes 0.000 claims description 3
- 101710185775 Squamous cell carcinoma antigen recognized by T-cells 3 Proteins 0.000 claims description 3
- 102000004887 Transforming Growth Factor beta Human genes 0.000 claims description 3
- 108090001012 Transforming Growth Factor beta Proteins 0.000 claims description 3
- 230000004913 activation Effects 0.000 claims description 3
- 108010026331 alpha-Fetoproteins Proteins 0.000 claims description 3
- 229910002092 carbon dioxide Inorganic materials 0.000 claims description 3
- 239000001569 carbon dioxide Substances 0.000 claims description 3
- 210000002950 fibroblast Anatomy 0.000 claims description 3
- 230000002608 insulinlike Effects 0.000 claims description 3
- 230000035755 proliferation Effects 0.000 claims description 3
- 206010042863 synovial sarcoma Diseases 0.000 claims description 3
- 208000037398 BCR-ABL1 negative atypical chronic myeloid leukemia Diseases 0.000 claims description 2
- NMABFUGAUQKBEM-LARVRRBISA-N CN1C=C(C[C@H](N)C(=O)O)C2=CC=CC=C12.CN1C=C(C[C@H](N)C(=O)O)C2=CC=CC=C12 Chemical compound CN1C=C(C[C@H](N)C(=O)O)C2=CC=CC=C12.CN1C=C(C[C@H](N)C(=O)O)C2=CC=CC=C12 NMABFUGAUQKBEM-LARVRRBISA-N 0.000 claims description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims description 2
- 102000003846 Carbonic anhydrases Human genes 0.000 claims description 2
- 108090000209 Carbonic anhydrases Proteins 0.000 claims description 2
- 102000001301 EGF receptor Human genes 0.000 claims description 2
- 108060006698 EGF receptor Proteins 0.000 claims description 2
- 206010016654 Fibrosis Diseases 0.000 claims description 2
- 102000009465 Growth Factor Receptors Human genes 0.000 claims description 2
- 108010009202 Growth Factor Receptors Proteins 0.000 claims description 2
- 208000037379 Myeloid Chronic Atypical BCR-ABL Negative Leukemia Diseases 0.000 claims description 2
- 201000007224 Myeloproliferative neoplasm Diseases 0.000 claims description 2
- 102100027244 U4/U6.U5 tri-snRNP-associated protein 1 Human genes 0.000 claims description 2
- 101710155955 U4/U6.U5 tri-snRNP-associated protein 1 Proteins 0.000 claims description 2
- 201000004892 atypical chronic myeloid leukemia Diseases 0.000 claims description 2
- 230000008472 epithelial growth Effects 0.000 claims description 2
- 230000004761 fibrosis Effects 0.000 claims description 2
- 230000002062 proliferating effect Effects 0.000 claims description 2
- 210000002307 prostate Anatomy 0.000 claims description 2
- 208000002250 Hematologic Neoplasms Diseases 0.000 claims 4
- 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims 3
- 102100040678 Programmed cell death protein 1 Human genes 0.000 claims 3
- 101710089372 Programmed cell death protein 1 Proteins 0.000 claims 3
- 102000007471 Adenosine A2A receptor Human genes 0.000 claims 2
- 108010085277 Adenosine A2A receptor Proteins 0.000 claims 2
- 102100038078 CD276 antigen Human genes 0.000 claims 2
- 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims 2
- 101000666896 Homo sapiens V-type immunoglobulin domain-containing suppressor of T-cell activation Proteins 0.000 claims 2
- 102000002698 KIR Receptors Human genes 0.000 claims 2
- 108010043610 KIR Receptors Proteins 0.000 claims 2
- 102100020862 Lymphocyte activation gene 3 protein Human genes 0.000 claims 2
- 108010061593 Member 14 Tumor Necrosis Factor Receptors Proteins 0.000 claims 2
- 108700030875 Programmed Cell Death 1 Ligand 2 Proteins 0.000 claims 2
- 102100024213 Programmed cell death 1 ligand 2 Human genes 0.000 claims 2
- 101710136122 Tryptophan 2,3-dioxygenase Proteins 0.000 claims 2
- 102000057288 Tryptophan 2,3-dioxygenases Human genes 0.000 claims 2
- 102100028785 Tumor necrosis factor receptor superfamily member 14 Human genes 0.000 claims 2
- 102100038929 V-set domain-containing T-cell activation inhibitor 1 Human genes 0.000 claims 2
- 102100038282 V-type immunoglobulin domain-containing suppressor of T-cell activation Human genes 0.000 claims 2
- 102000006639 indoleamine 2,3-dioxygenase Human genes 0.000 claims 2
- 108020004201 indoleamine 2,3-dioxygenase Proteins 0.000 claims 2
- 101710144268 B- and T-lymphocyte attenuator Proteins 0.000 claims 1
- 102100028737 CAP-Gly domain-containing linker protein 1 Human genes 0.000 claims 1
- 101100476671 Caenorhabditis elegans sart-3 gene Proteins 0.000 claims 1
- 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims 1
- 101710083479 Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 claims 1
- 101000954709 Homo sapiens Doublecortin domain-containing protein 2 Proteins 0.000 claims 1
- 101000985516 Homo sapiens Hermansky-Pudlak syndrome 5 protein Proteins 0.000 claims 1
- 101000614481 Homo sapiens Kidney-associated antigen 1 Proteins 0.000 claims 1
- 101000821981 Homo sapiens Sarcoma antigen 1 Proteins 0.000 claims 1
- 101000665137 Homo sapiens Scm-like with four MBT domains protein 1 Proteins 0.000 claims 1
- 101000955999 Homo sapiens V-set domain-containing T-cell activation inhibitor 1 Proteins 0.000 claims 1
- 108010031794 IGF Type 1 Receptor Proteins 0.000 claims 1
- 102000037982 Immune checkpoint proteins Human genes 0.000 claims 1
- 108091008036 Immune checkpoint proteins Proteins 0.000 claims 1
- 108060003951 Immunoglobulin Proteins 0.000 claims 1
- 229940126547 T-cell immunoglobulin mucin-3 Drugs 0.000 claims 1
- 208000007536 Thrombosis Diseases 0.000 claims 1
- 108010079206 V-Set Domain-Containing T-Cell Activation Inhibitor 1 Proteins 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 201000000053 blastoma Diseases 0.000 claims 1
- 108010038764 cytoplasmic linker protein 170 Proteins 0.000 claims 1
- 210000001151 cytotoxic T lymphocyte Anatomy 0.000 claims 1
- 230000000694 effects Effects 0.000 claims 1
- 201000008184 embryoma Diseases 0.000 claims 1
- 102000018358 immunoglobulin Human genes 0.000 claims 1
- 239000003446 ligand Substances 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 206010044412 transitional cell carcinoma Diseases 0.000 claims 1
- 210000003741 urothelium Anatomy 0.000 claims 1
- 230000002489 hematologic effect Effects 0.000 description 4
- 108010021064 CTLA-4 Antigen Proteins 0.000 description 2
- 229940045513 CTLA4 antagonist Drugs 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 210000001635 urinary tract Anatomy 0.000 description 2
- 102000006306 Antigen Receptors Human genes 0.000 description 1
- 108010083359 Antigen Receptors Proteins 0.000 description 1
- 102000004867 Hydro-Lyases Human genes 0.000 description 1
- 108090001042 Hydro-Lyases Proteins 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000005746 immune checkpoint blockade Effects 0.000 description 1
- 201000000050 myeloid neoplasm Diseases 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 229960004799 tryptophan Drugs 0.000 description 1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2023046113A JP2023078376A (ja) | 2017-04-21 | 2023-03-23 | 遺伝子療法 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1706410.6A GB201706410D0 (en) | 2017-04-21 | 2017-04-21 | Type 1 interferon gene therapy |
| GB1706410.6 | 2017-04-21 | ||
| GB1801511.5 | 2018-01-30 | ||
| GBGB1801511.5A GB201801511D0 (en) | 2018-01-30 | 2018-01-30 | Gene therapy |
| PCT/EP2018/060238 WO2018193119A1 (en) | 2017-04-21 | 2018-04-20 | Gene therapy |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023046113A Division JP2023078376A (ja) | 2017-04-21 | 2023-03-23 | 遺伝子療法 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020517261A JP2020517261A (ja) | 2020-06-18 |
| JP2020517261A5 true JP2020517261A5 (https=) | 2021-06-10 |
| JP7252135B2 JP7252135B2 (ja) | 2023-04-04 |
Family
ID=62165525
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019556929A Active JP7252135B2 (ja) | 2017-04-21 | 2018-04-20 | 遺伝子療法 |
| JP2023046113A Pending JP2023078376A (ja) | 2017-04-21 | 2023-03-23 | 遺伝子療法 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023046113A Pending JP2023078376A (ja) | 2017-04-21 | 2023-03-23 | 遺伝子療法 |
Country Status (23)
| Country | Link |
|---|---|
| US (1) | US20200078408A1 (https=) |
| EP (2) | EP4491233A3 (https=) |
| JP (2) | JP7252135B2 (https=) |
| KR (1) | KR102733541B1 (https=) |
| CN (1) | CN110785488A (https=) |
| AU (1) | AU2018253959B2 (https=) |
| BR (1) | BR112019021953A2 (https=) |
| CA (1) | CA3060145A1 (https=) |
| DK (1) | DK3612624T3 (https=) |
| ES (1) | ES2995785T3 (https=) |
| FI (1) | FI3612624T3 (https=) |
| HR (1) | HRP20241603T1 (https=) |
| HU (1) | HUE069690T2 (https=) |
| IL (2) | IL270028B2 (https=) |
| LT (1) | LT3612624T (https=) |
| MX (2) | MX2024012023A (https=) |
| PL (1) | PL3612624T3 (https=) |
| PT (1) | PT3612624T (https=) |
| RS (1) | RS66264B1 (https=) |
| SG (1) | SG11201909814WA (https=) |
| SI (1) | SI3612624T1 (https=) |
| SM (1) | SMT202400506T1 (https=) |
| WO (1) | WO2018193119A1 (https=) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113710796A (zh) * | 2019-02-09 | 2021-11-26 | 美国卫生和人力服务部 | 作为减少或预防转移、治疗自身免疫和炎性病症以及重新平衡免疫环境和失调的小生境的平台的基因修饰的造血干细胞和祖细胞(hspc)及间充质细胞 |
| CA3129036A1 (en) * | 2019-02-22 | 2020-08-27 | Oncolytics Biotech Inc. | T cell repertoire dynamics and oncolytic viral therapy |
| EP3941490A4 (en) * | 2019-03-20 | 2023-01-04 | 2seventy bio, Inc. | ADOPTIVE CELLULAR THERAPY |
| CN112280829B (zh) * | 2020-04-07 | 2023-12-26 | 南方科技大学 | 一种试剂盒、样本标记方法、单细胞测序方法 |
| KR20230010231A (ko) * | 2020-05-11 | 2023-01-18 | 아빈투스 바이오, 인코포레이티드 | 생체내 형질도입을 위한 벡터 및 방법 |
| GB202007169D0 (en) * | 2020-05-14 | 2020-07-01 | Ospedale San Raffaele Srl | Epidermal growth factor receptor |
| EP4161536A4 (en) * | 2020-06-04 | 2024-08-14 | Carisma Therapeutics Inc. | Novel constructs for chimeric antigen receptors |
| CN114426953A (zh) * | 2020-10-29 | 2022-05-03 | 未来智人再生医学研究院(广州)有限公司 | 一种表达il-12的多能干细胞衍生物及应用 |
| JP2023547692A (ja) * | 2020-11-03 | 2023-11-13 | ▲広▼州▲輯▼因医▲療▼科技有限公司 | 細胞製剤、造血幹細胞を特徴付けるためのタンパク質の使用、及び造血幹細胞を判定するための方法 |
| CN114807155A (zh) * | 2021-01-18 | 2022-07-29 | 华东师范大学 | 用于基因编辑的组合物及其应用 |
| CN115819612A (zh) * | 2022-03-11 | 2023-03-21 | 郑州大学第一附属医院 | 表达载体、宿主细胞、抗肿瘤药物组合物及其应用 |
| WO2024068617A1 (en) * | 2022-09-26 | 2024-04-04 | Institut Curie | Myeloid cells expressing il-2 and uses thereof for quick anticancer therapy |
| CN120603934A (zh) * | 2023-02-08 | 2025-09-05 | 国立大学法人九州大学 | 能够在肿瘤组织内分化成m2巨噬细胞且分化成m2巨噬细胞时表达炎性细胞因子的细胞和含有该细胞的组合物 |
| WO2024194223A2 (en) * | 2023-03-17 | 2024-09-26 | Ospedale San Raffaele S.R.L. | Gene therapy |
| WO2025217427A1 (en) * | 2024-04-11 | 2025-10-16 | Genenta Science S.P.A. | Combination immunotherapy of solid cancers |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9803351D0 (en) * | 1998-02-17 | 1998-04-15 | Oxford Biomedica Ltd | Anti-viral vectors |
| GB0009760D0 (en) | 2000-04-19 | 2000-06-07 | Oxford Biomedica Ltd | Method |
| SI2856876T1 (en) * | 2007-03-30 | 2018-04-30 | Memorial Sloan-Kettering Cancer Center | Constitutive expression of costimulatory ligands on adoptively transferred T lymphocytes |
| PL2424571T3 (pl) * | 2009-04-30 | 2020-10-19 | Ospedale San Raffaele S.R.L | Wektor genowy |
| AU2013374345A1 (en) * | 2013-01-17 | 2015-08-06 | Moderna Therapeutics, Inc. | Signal-sensor polynucleotides for the alteration of cellular phenotypes |
| US10562952B2 (en) * | 2015-09-10 | 2020-02-18 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Anti-CD276 chimeric antigen receptors |
| WO2017093969A1 (en) * | 2015-12-04 | 2017-06-08 | Novartis Ag | Compositions and methods for immunooncology |
-
2018
- 2018-04-20 IL IL270028A patent/IL270028B2/en unknown
- 2018-04-20 BR BR112019021953-6A patent/BR112019021953A2/pt unknown
- 2018-04-20 RS RS20241344A patent/RS66264B1/sr unknown
- 2018-04-20 HU HUE18724470A patent/HUE069690T2/hu unknown
- 2018-04-20 HR HRP20241603TT patent/HRP20241603T1/hr unknown
- 2018-04-20 LT LTEPPCT/EP2018/060238T patent/LT3612624T/lt unknown
- 2018-04-20 DK DK18724470.2T patent/DK3612624T3/da active
- 2018-04-20 WO PCT/EP2018/060238 patent/WO2018193119A1/en not_active Ceased
- 2018-04-20 CN CN201880040639.9A patent/CN110785488A/zh active Pending
- 2018-04-20 IL IL320674A patent/IL320674A/en unknown
- 2018-04-20 EP EP24202037.8A patent/EP4491233A3/en active Pending
- 2018-04-20 SI SI201831181T patent/SI3612624T1/sl unknown
- 2018-04-20 PT PT187244702T patent/PT3612624T/pt unknown
- 2018-04-20 SM SM20240506T patent/SMT202400506T1/it unknown
- 2018-04-20 FI FIEP18724470.2T patent/FI3612624T3/fi active
- 2018-04-20 AU AU2018253959A patent/AU2018253959B2/en active Active
- 2018-04-20 SG SG11201909814W patent/SG11201909814WA/en unknown
- 2018-04-20 KR KR1020197034111A patent/KR102733541B1/ko active Active
- 2018-04-20 ES ES18724470T patent/ES2995785T3/es active Active
- 2018-04-20 CA CA3060145A patent/CA3060145A1/en active Pending
- 2018-04-20 EP EP18724470.2A patent/EP3612624B1/en active Active
- 2018-04-20 JP JP2019556929A patent/JP7252135B2/ja active Active
- 2018-04-20 US US16/604,484 patent/US20200078408A1/en active Pending
- 2018-04-20 PL PL18724470.2T patent/PL3612624T3/pl unknown
-
2019
- 2019-10-21 MX MX2024012023A patent/MX2024012023A/es unknown
- 2019-10-21 MX MX2024012024A patent/MX2024012024A/es unknown
-
2023
- 2023-03-23 JP JP2023046113A patent/JP2023078376A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020517261A5 (https=) | ||
| US20220204628A1 (en) | Compositions and methods for targeted immunomodulatory antibodies and fusion proteins | |
| Marin-Acevedo et al. | Cancer immunotherapy beyond immune checkpoint inhibitors | |
| Maus et al. | Making better chimeric antigen receptors for adoptive T-cell therapy | |
| Baxevanis et al. | Cancer immunotherapy | |
| Dotti et al. | Design and development of therapies using chimeric antigen receptor‐expressing T cells | |
| HRP20241603T1 (hr) | Genska terapija | |
| Lin et al. | Cellular immunotherapy for malignant gliomas | |
| Hinrichs | Molecular pathways: breaking the epithelial cancer barrier for chimeric antigen receptor and T-cell receptor gene therapy | |
| US20230398216A1 (en) | Chimeric activation receptors | |
| Shirjang et al. | Promising immunotherapy: Highlighting cytokine‐induced killer cells | |
| Xu et al. | Chimeric antigen receptor T-cell therapy: challenges and opportunities in lung cancer | |
| Yu et al. | CAR NK cell therapy for solid tumors: Potential and challenges | |
| Knight et al. | Beyond immune checkpoint inhibitors: emerging targets in melanoma therapy | |
| Azizi et al. | T-cell receptor and chimeric antigen receptor in solid cancers: current landscape, preclinical data and insight into future developments | |
| Nardo et al. | Associação Brasileira de Hematologia, Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. Review article: Cell therapy in solid tumors | |
| Kucharczyk et al. | Adoptive T-cell therapy in sarcomas | |
| US20240148867A1 (en) | Methods of treating cancer with a combination of adoptive cell therapy and a targeted immunocytokine | |
| Rotte et al. | Promising immunotherapeutic approaches in clinical trials | |
| HK40120910A (en) | FC-ε CAR | |
| HK40121595A (en) | FC-ε CAR | |
| HK40120909A (en) | FC-ε CAR | |
| HK40120344A (en) | FC-ε CAR | |
| HK40120343A (en) | FC-ε CAR | |
| HK40120341A (en) | FC-ε CAR |